Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist - Wikidata - wikimedia - TriplyDB

Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist

Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist

http://www.wikidata.org/entity/Q28475994

about

Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer Salinomycin as a drug for targeting human cancer stem cells Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion Environmental Ligands of the Aryl Hydrocarbon Receptor and Their Effects in Models of Adult Liver Progenitor Cells Cancer Stem and Progenitor-Like Cells as Pharmacological Targets in Breast Cancer Treatment Development of Species-Specific Ah Receptor-Responsive Third Generation CALUX Cell Lines with Enhanced Responsiveness and Improved Detection Limits IMD-0354 targets breast cancer stem cells: a novel approach for an adjuvant to chemotherapy to prevent multidrug resistance in a murine model Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation Strigolactones: a novel class of phytohormones that inhibit the growth and survival of breast cancer cells and breast cancer stem-like enriched mammosphere cells.Correlations of ALDH1 expression with molecular subtypes and ABCG2 in breast cancer Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumor.2-(4-Hydroxy-3-methoxyphenyl)-benzothiazole suppresses tumor progression and metastatic potential of breast cancer cells by inducing ubiquitin ligase CHIP.Collagen density regulates xenobiotic and hypoxic response of mammary epithelial cells The culture of cancer cell lines as tumorspheres does not systematically result in cancer stem cell enrichment.Cancer stem cells as a target population for drug discovery.Activation of the aryl hydrocarbon receptor by TCDD inhibits mammary tumor metastasis in a syngeneic mouse model of breast cancer Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.Tryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cells The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.Revealing the anti-tumor effect of artificial miRNA p-27-5p on human breast carcinoma cell line T-47D.Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells.Cancer stem cells and chemoresistance: The smartest survives the raid Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition.Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.Breast cancer-initiating cells: insights into novel treatment strategies.An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells Oxazaphosphorine bioactivation and detoxification The role of xenobiotic receptors.Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity.Breast cancer stem cell enrichment and isolation by mammosphere culture and its potential diagnostic applications.Cancer stem cells and their implication in breast cancer.Stand-Sit Microchip for High-Throughput, Multiplexed Analysis of Single Cancer Cells.Concise Review: Emerging Drugs Targeting Epithelial Cancer Stem-Like Cells.Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target.The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells.Tranilast binds to aβ monomers and promotes aβ fibrillation.Activation of aryl hydrocarbon receptor (ahr) by tranilast, an anti-allergy drug, promotes miR-302 expression and cell reprogramming.Suppression of the allogeneic response by the anti-allergy drug N-(3,4-dimethoxycinnamonyl) anthranilic acid results from T-cell cycle arrest.Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast.Nanocarrier based approaches for targeting breast cancer stem cells.

P2860

Q21134780-DA180989-38BF-415D-BEF1-A4678C150802 Q21285139-416C43FA-6715-443F-B839-8145E37FAE34 Q22000757-A0743C24-D61B-4076-AE83-DEDC97B366B5 Q26747621-5CD36AC6-1308-4089-BDE5-30ABFD07C30F Q27024816-6EEEA508-487A-4BC4-BA42-70B6F6F954A0 Q28388445-95F91BE0-C4FB-4C8D-8068-BC971BABDE76 Q28535709-2A009137-51DE-4EB3-96B2-CA86F168E432 Q28818789-0D485DBC-A03A-4A80-83E9-0A52C73E7674 Q33353296-5A1DAD10-1C8E-4BE4-BA02-6C5EF5BDE1A4 Q33972932-07DF806A-9701-4759-BB8E-2A0523A100F6 Q34181672-3A0308FB-E30D-4D37-BDD2-BAB044F2016E Q34530928-C88D0F3D-1093-4FCF-B257-A74BFA613A54 Q35071054-3B86805F-7FBA-4C5D-8EBE-3F3361C70698 Q35107800-FD2221AA-B64C-4444-9957-6DC4F90A730F Q35390334-3AB891CC-ED80-4618-977C-1196C82801AE Q35551010-C76BA9E6-45FE-4BBD-9629-B949D84AFFFB Q35667189-842FFCE4-A7CB-4CD9-85D6-E01F7F7150A1 Q35813504-7B2DA6C8-8FEE-4428-90DD-0334F862B93B Q35960211-83831475-D225-47F2-8558-DDF2D5C49A93 Q36057353-5232F453-CBA5-41E0-9C6F-9A3D144A90C3 Q36335539-35788187-A093-46E6-95BA-0E1DC495CB2F Q36730432-236A3C99-E434-4A5B-B550-ECD0490CAB3F Q36736295-EFDF127F-C4F6-4B76-AFAE-CDE7CFA6DBFE Q36747524-D662A381-1671-419E-BB0A-F8E077F4A089 Q37108803-4D65EBC5-B974-424D-ABCD-2BAA86349335 Q37129899-62F15B06-33C9-4C36-84BF-94F9B13F1DEB Q37357710-32324E0C-E8DF-43D2-8198-6381640903B4 Q37386327-DCD9384F-7D8A-4020-A552-E012BB8BE895 Q38040614-7869AB28-AF5D-4468-9F13-998445623E73 Q38068937-26025EF8-6771-4605-8555-36E180009E46 Q38207159-7EAE9EC0-24DD-4CDA-8C9D-860F7A84A9B5 Q38825711-C5F2EFA9-E879-41BB-9EF1-5CECDED944B2 Q39112034-61169950-D208-4D58-B32A-4942351CC142 Q39309007-3AACDB17-627A-40CD-8B7C-D535D2CFD839 Q40027291-158D8A54-4B0A-4634-8D0A-710980A3A466 Q42173483-F519439E-A9D4-4626-85AB-918388955367 Q42569611-F52C1188-7249-4909-AD1A-9BEE1DE32034 Q46526307-DC896DFE-CA02-4634-B7A5-6C577460780A Q47101405-78416F2C-19B6-4F14-8F66-356105EEE378 Q48209273-3CD15028-B97B-4DA7-B141-45E82135AD64

P2860

Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist

http://www.wikidata.org/entity/Q28475994

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Breast cancer stem-like cells ...... l hydrocarbon receptor agonist

@ast

Breast cancer stem-like cells ...... l hydrocarbon receptor agonist

@en

Breast cancer stem-like cells ...... l hydrocarbon receptor agonist

@nl

type

label

Breast cancer stem-like cells ...... l hydrocarbon receptor agonist

@ast

Breast cancer stem-like cells ...... l hydrocarbon receptor agonist

@en

Breast cancer stem-like cells ...... l hydrocarbon receptor agonist

@nl

prefLabel

Breast cancer stem-like cells ...... l hydrocarbon receptor agonist

@ast

Breast cancer stem-like cells ...... l hydrocarbon receptor agonist

@en

Breast cancer stem-like cells ...... l hydrocarbon receptor agonist

@nl

P1433

Q28475994-7A02EF26-F30A-4F44-AC64-A44264D9006B

P1476

Q28475994-63BA11E1-57A3-4B87-A134-FB7C6FE625EF

P2093

Q28475994-07AB152F-9A5D-414F-88DD-790C3B497C37

Q28475994-51037384-5025-4448-B6CD-355614A426AB

Q28475994-A09A2563-663A-4388-B7A9-F506F0323573

Q28475994-C6D26F9C-ABBF-40A5-B958-377AFD6CF3CD

Q28475994-DB864E20-1767-46B8-A7EF-B838A749E8BA

Q28475994-F3F8F784-138F-47E5-B300-A16C1D69FAE4

P2860

Q28475994-01473C56-6EEB-4EB4-8991-23C5EB2BAADB

Q28475994-08C7321C-6C0D-4814-BA8C-9CB6BE73AD05

Q28475994-09F4FD8A-FAD4-433C-8630-3989FE573719

Q28475994-0FC0B7FC-15BB-4614-8593-5DCC437119ED

Q28475994-127D67C7-253A-461A-9B97-56B46179026C

Q28475994-1D040171-CF82-4059-B84C-3D53557674E5

Q28475994-1E756883-2492-4B89-A979-FEBEBB780EE8

Q28475994-21059B82-E847-459F-BAA5-036715FCF3D1

Q28475994-24B0F21E-4E69-4009-AC83-F275C9F41CEA

Q28475994-24E1D8BA-24E7-43D1-9531-5DDBA4C01C42

P304

Q28475994-4ED83F4A-DBAD-4627-9462-6328AFD18F99

P31

Q28475994-AAAFEB92-4E5C-4393-AB4C-72869B7F634C

P3181

Q28475994-0A798DC9-FD84-456C-B7A2-673C7790B256

P356

Q28475994-C257CEE4-55F1-42FD-B0D5-3EF868D8CE96

P407

Q28475994-5E825B92-28D2-46E2-90F5-CEDD5A2E022D

P433

Q28475994-3994FAC3-A8B5-491C-BA25-4738FC5109A1

P478

Q28475994-ABEE6B55-19BD-42E7-A9F6-083D63C365D3

P577

Q28475994-1B07107D-6D68-4911-894C-1987DD3ED500

P5875

Q28475994-28E6EC26-A937-4ABD-B3AB-C8887F939C59

P698

Q28475994-066D3D32-F35B-4770-9F7D-D6BFE721A2B5

P921

Q28475994-510AD159-EC32-4AE5-9921-C37EFD218B37

P932

Q28475994-4C29A5B1-0882-47D8-9530-2D10CCEE6F57

P3181

P356

JOURNAL.PONE.0013831

P1433

P1476

Breast cancer stem-like cells ...... l hydrocarbon receptor agonist

@en

P2093

Anna Toulina

http://www.w3.org/2001/XMLSchema#string

Gérald J Prud'homme

http://www.w3.org/2001/XMLSchema#string

Olga Ace

http://www.w3.org/2001/XMLSchema#string

Serge Jothy

http://www.w3.org/2001/XMLSchema#string

Venkateswaran Subramaniam

http://www.w3.org/2001/XMLSchema#string

Yelena Glinka

http://www.w3.org/2001/XMLSchema#string

P2860

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

The epithelial-mesenchymal transition generates cells with properties of stem cells

The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

7-ketocholesterol is an endogenous modulator for the arylhydrocarbon receptor

Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals

2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses tumor necrosis factor-alpha and anti-CD40-induced activation of NF-kappaB/Rel in dendritic cells: p50 homodimer activation is not affected

Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

P304

e13831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1849059

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0013831

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47756114

http://www.w3.org/2001/XMLSchema#string

P698

21072210

http://www.w3.org/2001/XMLSchema#string

P921

aryl hydrocarbon receptor agonist

P932

2972222

http://www.w3.org/2001/XMLSchema#string